|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006141,
umls-concept:C0017262,
umls-concept:C0027651,
umls-concept:C0040690,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0332307,
umls-concept:C0441800,
umls-concept:C0597357,
umls-concept:C1334274,
umls-concept:C1517945,
umls-concept:C2911684
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2000-3-17
|
|
pubmed:abstractText |
Loss of transforming growth factor beta type II receptor (TGFbeta-RII) expression has been associated with resistance to TGFbeta-mediated inhibition of cell proliferation and tumour progression. We investigated whether the expression of TGFbeta-RII is related to the progression of human breast cancer and whether there is a correlation between TGFbeta-RII expression and phenotypic markers of biological aggressiveness.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0309-0167
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
168-77
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10672063-Adult,
pubmed-meshheading:10672063-Aged,
pubmed-meshheading:10672063-Aged, 80 and over,
pubmed-meshheading:10672063-Breast,
pubmed-meshheading:10672063-Breast Neoplasms,
pubmed-meshheading:10672063-Carcinoma, Ductal, Breast,
pubmed-meshheading:10672063-Carcinoma in Situ,
pubmed-meshheading:10672063-Disease Progression,
pubmed-meshheading:10672063-Female,
pubmed-meshheading:10672063-Humans,
pubmed-meshheading:10672063-Hyperplasia,
pubmed-meshheading:10672063-Immunohistochemistry,
pubmed-meshheading:10672063-Middle Aged,
pubmed-meshheading:10672063-Neoplasm Invasiveness,
pubmed-meshheading:10672063-Neoplasm Staging,
pubmed-meshheading:10672063-Protein-Serine-Threonine Kinases,
pubmed-meshheading:10672063-Receptors, Transforming Growth Factor beta
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.
|
|
pubmed:affiliation |
Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232-2561, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
